• Featured Product
  • KD/KO Validated

Placental Growth Factor Polyclonal antibody

Placental Growth Factor Polyclonal Antibody for IHC, ELISA

Host / Isotype

Rabbit / IgG


human, mouse and More (1)





Cat no : 10642-1-AP


D12S1900, PGF, PGFL, PIGF, Placenta growth factor, placental growth factor, PLGF, PlGF 2, SHGC 10760

Tested Applications

Positive WB detected inhuman placenta tissue, mouse placenta tissue
Positive IHC detected inhuman placenta tissue, human meningioma tissue, human kidney tissue, human breast cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

Western Blot (WB)WB : 1:500-1:1000
Immunohistochemistry (IHC)IHC : 1:200-1:800
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

10642-1-AP targets Placental Growth Factor in IF, IHC, ELISA applications and shows reactivity with human, mouse samples.

Tested Reactivity human, mouse
Cited Reactivityhuman, mouse, rat
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen Placental Growth Factor fusion protein Ag0969
Full Name placental growth factor
Calculated Molecular Weight 25 kDa
Observed Molecular Weight 50 kDa
GenBank Accession NumberBC007789
Gene Symbol PGF
Gene ID (NCBI) 5228
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Placenta growth factor (PLGF) is a homodimeric glycoprotein, 46-50 kDa in size, belonging to the vascular endothelial growth factor (VEGF) sub-family. It plays an important role in pathological VEGF-driven angiogenesis. PLGF is expressed not only in placental cells but also in colon and mammary carcinomas. It acts as a primary inflammatory instigator of atherosclerotic plaque instability and thus may be useful as a risk-predicting biomarker in patients with acute coronary syndromes (ACS).


Product Specific Protocols
WB protocol for Placental Growth Factor antibody 10642-1-APDownload protocol
IHC protocol for Placental Growth Factor antibody 10642-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols




Global gene expression profiling of somatic motor neuron populations with different vulnerability identify molecules and pathways of degeneration and protection.

Authors - Hedlund E


Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells.

Authors - Yudong Song
  • KD Validated

Biomed Pharmacother

HIF-1α inhibitor YC-1 suppresses triple-negative breast cancer growth and angiogenesis by targeting PlGF/VEGFR1-induced macrophage polarization

Authors - Yan Li

Cancers (Basel)

Occurrence of Fibrotic Tumor Vessels in Grade I Meningiomas Is Strongly Associated with Vessel Density, Expression of VEGF, PlGF, IGFBP-3 and Tumor Recurrence.

Authors - Katharina Hess

Diabetes Obes Metab

Polarized macrophages promote gestational beta cell growth through extracellular signal-regulated kinase 5 signalling.

Authors - Yinan Jiang

Int J Mol Sci

Alzheimer's Amyloid β Peptide Induces Angiogenesis in an Alzheimer's Disease Model Mouse through Placental Growth Factor and Angiopoietin 2 Expressions

Authors - Abdullah Md Sheikh